LA Biomedical Research at Harbor UCLA Medical Center SC - SOM230B2219 — Torrance, California

LA Biomedical Research at Harbor UCLA Medical Center SC - SOM230B2219 is a clinical research site located in Torrance, California, United States 90502.

Crixeo Clinical Trials Trust Score: 9/100 (FAILING). This profile has not yet been claimed by the site owner.

LA Biomedical Research at Harbor UCLA Medical Center SC - SOM230B2219 has participated in 1 clinical trials.

Therapeutic areas: Cushing's Disease, Acromegaly.

Sponsors: Novartis Pharmaceuticals.

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Torrance

Browse all research sites in California · View every site in Torrance

Sponsor Feasibility Report

Trust Score: 9/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for LA Biomedical Research at Harbor UCLA Medical Center SC - SOM230B2219?

LA Biomedical Research at Harbor UCLA Medical Center SC - SOM230B2219 has a Crixeo Trust Score of 9/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has LA Biomedical Research at Harbor UCLA Medical Center SC - SOM230B2219 conducted?

LA Biomedical Research at Harbor UCLA Medical Center SC - SOM230B2219 has 1 clinical trials on record. Their work covers Cushing's Disease, Acromegaly.

Is LA Biomedical Research at Harbor UCLA Medical Center SC - SOM230B2219 accredited by Crixeo Clinical Trials?

LA Biomedical Research at Harbor UCLA Medical Center SC - SOM230B2219 has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about LA Biomedical Research at Harbor UCLA Medical Center SC - SOM230B2219?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.